Showing results (161-170 of 757) with videos related to
Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|March 16, 2026
Natural history of chronic hepatitis B in untreated adults without cirrhosis according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysisDaniela Yucuma, Arthur Rakover, Zakary Ismail Warsop, et al.The Lancet. Gastroenterology & Hepatology|March 23, 2026
Indocyanine green fluorescence angiography for anastomotic perfusion assessment in colorectal surgery: a systematic review with meta-analysis, meta-regression, and trial sequential analysesÉanna J Ryan, Odhrán K Ryan, Neil Corrigan, et al.The Lancet. Gastroenterology & Hepatology|May 1, 2026
Effect of one or two cycles of dual immunotherapy with nivolumab and ipilimumab in patients with mismatch repair-deficient rectal cancer (RESET-R): interim results from a multicentre, single-arm, phase 2 trialLine Schmidt Tarpgaard, Laurids Østergaard Poulsen, Ismail Gögenur, et al.The Lancet. Gastroenterology & Hepatology|March 26, 2026
Transanal total mesorectal excision versus laparoscopic total mesorectal excision for mid and low rectal cancer (COLOR III): short-term outcomes of an international, multicentre, phase 3, randomised, controlled, non-inferiority trialJurriaan B Tuynman, Hongwei Yao, Laura R Moolenaar, et al.The Lancet. Gastroenterology & Hepatology|March 20, 2026
Who to test and reflex testing for hepatitis D virus infection: evidence and rationale to inform policy recommendations and future directionsSahar Bajis, Niklas Luhmann, Emi Okamoto, et al.The Lancet. Gastroenterology & Hepatology|May 19, 2026
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practiceGabor Liposits, Thierry André, Thomas Aparicio, et al.The Lancet. Gastroenterology & Hepatology|May 22, 2026
The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trialMan-Fung Yuen, Edward Gane, Jacinta A Holmes, et al.The Lancet. Gastroenterology & Hepatology|April 12, 2020
Liver transplantation in patients with alcohol-related liver disease: current status and future directionsPhilippe Mathurin, Michael R LuceyThe Lancet. Gastroenterology & Hepatology|May 27, 2026
Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trialLaura R Moolenaar, Mahsoem Ali, Theo J Aufenacker, et al.The Lancet. Gastroenterology & Hepatology|June 2, 2026
Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort studyJesse Pustjens, Katrine Tholstrup Bech, Guillem Pera, et al.Pageof 76